Etiology of severe acute respiratory infections among adults in northern Thailand using multiplex PCR: A post-COVID-19 surveillance study (2023-2024).

Publication date: Jun 09, 2026

The COVID-19 pandemic disrupted the circulation patterns of respiratory viruses. In tropical regions like Thailand, ongoing surveillance is essential to understand the etiology of severe acute respiratory infections (SARIs) in the post-pandemic era. We investigated the etiology of SARI among hospitalized adults in the post-pandemic era. We conducted a retrospective analysis of respiratory samples collected from adult patients (≥18 years) who were hospitalized at a regional hospital in Chiang Mai, Thailand, between November 2023 and April 2024 due to symptoms of SARI (fever of ≥38^0C, cough, and onset within 10 days). Sputum and/or nasopharyngeal swab were collected at admission and tested using a multiplex real-time PCR assay targeting 22 respiratory viruses and Mycoplasma pneumoniae (Siemens Healthineers Fast Track Diagnostics and Tellgen SARS-CoV-2 Nucleic Acid Detection Kit). Demographic, clinical, treatment, and comorbidity data were extracted from hospital records, and descriptive statistics were used to summarize patient characteristics and pathogen distribution. Among 101 hospitalized SARI patients (median age 62 years (interquartile range 43-71); 57 males), 47 (47%) tested positive for at least one respiratory pathogen. The most frequently detected viruses were adenovirus (17/101, 17%) and rhinovirus (13/101, 13%). Co-infections occurred in 9% (9/101) of cases. Seasonal trends showed peaks of influenza A and rhinovirus in January, while adenovirus and enterovirus circulated consistently throughout the study period. Nearly half of adult SARI cases were associated with viral pathogens. Other SARI etiologies could be due to bacterial or fungal infections not tested in our study. The high rate of empiric antibiotic use highlights the need for broader and rapid molecular diagnostics. Enhanced pathogen-specific surveillance is essential to guide evidence-based clinical management in the post-pandemic context.

Open Access PDF

Concepts Keywords
Pneumoniae Acute
Surveillance Adults
Thailand Etiology
Viral Hospitalized
Infections
Pandemic
Pathogen
Post
Respiratory
Sari
Severe
Surveillance
Tested
Thailand
Viruses

Semantics

Type Source Name
disease MESH respiratory infections
disease MESH COVID-19
disease MESH fever
disease MESH cough
disease MESH Co-infections
pathway KEGG Influenza A
disease MESH fungal infections
pathway REACTOME Reproduction
disease MESH included
disease MESH infections
disease MESH influenza
disease MESH severe acute respiratory syndrome
disease MESH bacterial infections
disease MESH pneumonia
disease MESH viral infections
drug DRUGBANK Methionine
drug DRUGBANK Aspartame
disease MESH strains
disease MESH parainfluenza
disease MESH death
disease MESH Bronchiolitis
disease MESH sore throat
disease MESH myalgia
disease MESH rhinorrhea
disease MESH headache
disease MESH chills
disease MESH vomiting
disease MESH hoarseness
disease MESH tuberculosis
pathway KEGG Tuberculosis
disease MESH obesity
disease MESH leukemia
disease MESH arthritis
disease MESH asthma
pathway KEGG Asthma
disease MESH epilepsy
disease MESH multiple myeloma
disease MESH systemic lupus erythematosus
pathway KEGG Systemic lupus erythematosus
disease MESH thalassemia
disease MESH cardiomegaly
disease MESH pneumomediastinum
disease MESH bacterial pneumonia
drug DRUGBANK Hyaluronic acid
drug DRUGBANK Cefalotin
disease MESH Dis
drug DRUGBANK (S)-Des-Me-Ampa
disease MESH adenovirus infections
disease MESH SHS
drug DRUGBANK Medical air
drug DRUGBANK Guanosine

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *